2024 Anne & Max Tanenbaum Symposium: Precision Medicine for Epilepsy and Related Neurodevelopmental and Neuropsychiatric Disorders
Join us for this year's Anne & Max Tanenbaum Symposium on October 10, 2024 at the BMO Centre, Krembil Research Tower, 60 Leonard Ave, Toronto. This year's topic is, "Precision Medicine for Epilepsy and Related Neurodevelopmental and Neuropsychiatric Disorders."
Hosted by Dr. Peter Carlen, Tanenbaum Chair in Neuroscience, the event will feature a series of talks from world-leading researchers followed by Q&A sessions.
Registration is FREE but required by October 7, 2024.
Details
October 10, 2024
8:30 am - 5:00 pm
BMO Centre, Krembil Research Tower
60 Leonard Avenue, Toronto
Program
8:30am – Registration
8:45-9:00am – Welcome
Dr. Peter Carlen
Dr. Jaideep Bains
9:00-10:30am – Genetics in Epilepsy: Optimizing Diagnoses and Treatment
Chair: Dr. Danielle Andrade
Dr. Danielle Andrade
Genetic Epilepsies: From Neurodevelopmental to Neurodegenerative Disorders
Dr. James Eubanks
Precision Medicine: How a Patient-Specific Mouse Model Facilitated the Identification of a Prospective treatment for CDKL5 Deficiency Disorder
Dr. Anne Bassett
Disease Mechanisms and Treatment in a Human Genetic Model of Schizophrenia
Q&A
10:30-10:45am – Break
10:45am-12:15pm – Mitochondria: Understudied Key Factor in Diagnosing and Treating Epilepsy
Chair: Dr. Ana Andreazza
Dr. Shebani Sethi
Keynote Speaker
Metabolic Psychiatry: Ketogenic therapy in Schizophrenia and Bipolar - Results from a Pilot Clinical Trial
Dr. Ana Andreazza and Jaehyoung Choi
Brain, Mitochondria & Metabolism: Transdiagnostic Dimensions, and Using AI to Assess Mitogene Risk in Bipolar and Other Neuropsychiatric Disorders
Q&A
12:15-1:45pm - Lunch Break and Posters from Labs and Interested Companies
1:45-3:15pm – New technologies for Precision Medicine in Brain Disorders
Chair: Dr. Peter Carlen
Dr. Peter Carlen
Using 2D and 3D (Organoid) Cerebral Cultures to Diagnose and Treat Developmental Epileptic Encephalopathies
Dr. Liliana Attisano
Developing Complex Human Brain Organoid Models
Dr. Amy Ramsey
AAV-Mediated Gene Therapy for GRIN Neurodevelopmental Disorder
Q&A
3:15-3:30pm – Break
3:30-4:45pm – Precision Medicine and Industry
Chair: Dr. Miron Derchansky
Dr. Mark Tarnopolsky
The Use of Multi-Ingredient Supplements to Target Mitochondrial Dysfunction in Neurological Disorders
Dr. Miron Derchansky
De-Risking Clinical Trials with Precision Medicine and Digital Biomarkers
Dr. Amza Ali
Precision and Imprecision Medicine: Outreach to the Developing World
Q&A
4:45-5:00pm – Closing Remarks
2024 Tanenbaum Symposium - Now Open for Registration!
